XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenues:    
Total revenues $ 16,437 $ 33,293
Operating expenses:    
Cost of products 3,266 6,592
Research and development expenses 7,329 9,951
Selling, general and administrative expenses 10,446 24,487
Intangible asset amortization 201 1,767
Changes in fair value of related party contingent consideration 2,134 2,968
Restructuring costs 1,228 153
Total operating expenses 24,604 45,918
Operating loss (8,167) (12,625)
Investment and other income, net 817 54
Interest expense (3,062) (1,597)
Loss on deconsolidation of subsidiary (2,673) 0
Other income - changes in fair value of related party payable (307) (395)
Loss before income taxes (13,392) (14,563)
Income tax benefit (374) (2,327)
Net loss $ (13,018) $ (12,236)
Net income (loss) per share - basic (in dollars per share) $ (0.35) $ (0.32)
Net income (loss) per share - diluted (in dollars per share) $ (0.35) $ (0.32)
Weighted average number of shares outstanding - basic (in shares) 37,354 38,559
Weighted average number of shares outstanding - diluted (in shares) 37,354 38,559
Product sales    
Revenues:    
Total revenues $ 16,437 $ 33,161
License revenue    
Revenues:    
Total revenues $ 0 $ 132